drugset / Trial / NCT00356993

Phase I Study: Stop Smoking Therapy for Ontario Patients (STOP)

NCT00356993

NaSingle-groupOpen-labelTreatment

Summary

20% of Ontarians smoke. There was a decline in smoking prevalence from 1995 but it has remained unchanged since 2002. This rate of smoking cessation has not kept up with the rest of Canada. A new strategy is necessary to increase the number of smokers making quit attempts and to increase the odds of quitting long term.The goal of this study is to evaluate the methods and effectiveness of providing nicotine replacement (NRT) to Ontario smokers. The study will develop an evidence-based protocol for providing NRT, provide faculty development on combining pharmacotherapy with behavioural interventions and will provide an evaluation framework to inform future coverage models.

Timeline

Start
2005-10
Primary completion
2018-03-30
Completion
2018-03-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Nicotine Unknown Other

Indications

No indication recorded.